Medicine recalls. The United Kingdom: Class 2 Medicines Recall: Hikma Pharmaceuticals USA Inc, Lorazepam 2mg/ml Injection and Lorazepam
The serum concentration of Lorazepam can be increased when it is combined with Quetiapine. lorazepam (ativan), pentobarbitone or diazepam on recall. Br
The risk or severity of adverse effects can be increased when Morphine is combined with Lorazepam. lorazepam (ativan), pentobarbitone or diazepam on recall.
The risk or severity of adverse effects can be increased when Lorazepam is combined with Trazodone. lorazepam (ativan), pentobarbitone or diazepam on recall.
The therapeutic efficacy of Lorazepam can be decreased when used in combination with Caffeine. lorazepam (ativan), pentobarbitone or diazepam on recall.
Please note that this voluntary market recall is being performed to the CONSUMER/USER level. The voluntary recall Lorazepam Injection 2 mg/
Medicine recalls. Canada: Recall: Teva-Lorazepam Tablet 1 mg. Health Canada announced that Teva Canada Ltd. is recalling Teva-Lorazepam
Amneal – Recall of lorazepam oral concentrate. On Aug, Amneal announced a consumer-level recall of thirteen lots of lorazepam oral.
The last Recall Enforcement Report for Lorazepam with NDC was Major Pharmaceuticals ; FDA Recall: Lorazepam. FDA Recall Lorazepam.
Comments